Global Demand For Immunity Probiotics Boosts Chr. Hansen
Ingredients specialist Chr. Hansen cites the global COVID-19 pandemic for driving up demand for probiotics in supplements and infant formula globally.
You may also be interested in...
Rising global demand for probiotics is the motivating factor behind Chr Hansen's $530m acquisition of US dietary supplements player UAS Laboratories.
RB CEO Laxman Narasimhan sees the potential for the company to establish a global supplements business built on the successes it has enjoyed in the US and China. The comments came as RB reported solid growth in the third quarter, despite struggles for its OTC brands.
Bayer invests $8m in medical dermatology specialist Azitra to advance development of OTC and cosmetic products harnessing the skin microbiome.